Cyclic AMP, a Mediator of GLP-1, Acts in Concert with Glucose and Tolbutamide to Increase Cytosolic Ca2+ in Pancreatic B-Cells
Cyclic AMP (cAMP) plays an important role in the regulation of islet B-cell function and stimulates insulin release in a glucose-dependent manner(1). Several physiologic peptides such as truncated glucagon-like peptide-1 (GLP-1), gastric inhibitory peptide (GIP) and glucagon are known to elevate cAMP level in islets and stimulate insulin release also in a glucose-dependent manner(1–4). It has been recently shown that both a rise in cAMP and these peptides increase the cytosolic free Ca2+ concentration ([Ca2+]i) in pancreatic B-cells(3–7), the key intracellular signal that triggers exocytosis of insulin(8,9). The increase in [Ca2+]i is also glucose-dependent(6) and is tightly linked to insulin release(3). However, the mechanisms for the glucose-dependent action of cAMP to increase [Ca2+]i is not well understood. Whether cAMP increases [Ca2+]i via specific cooperation with glucose, a fuel secretagogue, or also with other types of insulin secretagogues is of particular importance. Whether the glucose-dependent action of the peptides to increase [Ca2+]i is mediated by a rise in cAMP is not thoroughly determined.
KeywordsInsulin Release Pituitary Adenylate Cyclase Activate Polypeptide Gastric Inhibitory Polypeptide Stimulate Insulin Release Krebs Ringer Bicarbonate Buffer
Unable to display preview. Download preview PDF.
- 16.Ämmälä, C., Eliasson, L., Bokvist, K., Berggren, P.-O., Honkanen, R.E., Sjöholm, A., and Rorsman, P., 1994, Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic β cells, Proc. Natl. Acad. Sci. 91:4343–4347.PubMedCrossRefGoogle Scholar